Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: Results from a phase I/II clinical trial

Metabolism: Clinical and Experimental

Volumn 53, Issue 1, 2004, Pages 54-58

  Clement, Stephen ^a,c,d   Dandona, Paresh ^b,c,d   Still, J Gordon ^b,c,d   Kosutic, Gordana ^b,c,d  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c Diabetes Endocrinology Center of Western New York   (United States)

^d Nobex Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; FAT; GLUCOSE; HEMOGLOBIN A1C; HEXYL INSULIN MONOCONJUGATE 2; HUMAN INSULIN; INSULIN; PROTEIN; SHORT ACTING DRUG; UNCLASSIFIED DRUG;

ADULT; AMBLYOPIA; ANEMIA; AREA UNDER THE CURVE; ARTICLE; ASTHENIA; ATAXIA; BACKACHE; BLOOD SAMPLING; CALORIE; CAUCASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE SEVERITY; DIZZINESS; DOSE CALCULATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; HYPERGLYCEMIA; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEAL; NAUSEA; NERVOUSNESS; OPEN STUDY; PARESTHESIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANK SUM TEST; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; STATISTICAL SIGNIFICANCE; THIRST; URINARY URGENCY; XEROSTOMIA;

EID: 0347316399     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.07.021     Document Type: Article

References (15)

1. American Diabetes Association: Postprandial blood glucose. Diabetes Care 24:775-778, 2001
2. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
3. Mohan V, Vijayaprabha R, Rema M: Vascular complications in long-term South Indian NIDDM over 25 duration. Diabetes Res Clin Pract 31:133-140, 1996
4. Beghi E, Monticelli ML: Diabetic polyneuropathy in the elderly. Prevalence and risk factors in two geographic areas of Italy. Italian General Practitioner Study Group. Acta Neurol Scand 96:223-228, 1997
5. Bavenholm P, De Faire U, Landou C, et al: Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function. Eur Heart J 19:402-410, 1998
6. Cherrington A: Banting Lecture 1997: Control of glucose uptake and release by the liver in vivo. Diabetes 48:1198-1214, 1999
7. Nilsson LH, Hultman E: Liver and muscle glycogen in man after glucose and fructose infusion. Scand J Clin Lab Invest 33:5-10, 1974
8. 13C-nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest 97:126-132, 1996
9. Radziuk J: Hepatic glycogen formation by direct uptake of glucose following oral glucose loading in man. Can J Physiol Pharmacol 57:1196-1199, 1979
10. DeFeo P, Perriello G, De Cosmo S, et al: Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans. Diabetes 35:563-569, 1986
11. Ader M, Bergman N: Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol 258:E1020-E1032, 1990
12. Davidson JK: Hypoglycemia, in Conn RB (ed): Current Diagnosis (ed 7). Philadelphia, PA, Saunders, 1985, pp 747-752
13. Clement S, Still G, Kosutic G, et al: Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: The glucose stabilization effects of HIM2. Diabetes Tech Therapeut 4:459-466, 2002
14. Still JGL: Development of oral insulin: Progress and current status. Diabet Metab Res Rev 18:S29-37, 2002 (suppl)
15. Kipnes M, Dandona P, Tripathy D, et al: Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes. Diabetes Care 26:421-426, 2003